PATENT CLAIM ANALYSIS

Application Number: 15897122
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "017800"]

Abstract:
The present invention discloses a reconstituted lipoprotein modified by monosialoteterahexosyl ganglioside, an application in preparing a drug carrier thereof, and an application in preparing a drug for treating or preventing a disease associated with Aβ deposition thereof. Specifically, the present invention discloses an application of an appropriate amount of monosialoteterahexosyl ganglioside in modifying the reconstituted lipoprotein to increase an affinity of the reconstituted lipoprotein with amyloid β-protein (Aβ), and facilitating clearance of Aβ. Meanwhile, the reconstituted lipoprotein modified by monosialoteterahexosyl ganglioside is used as a multi-mode nano carrier for preventing and treating central nervous system diseases, and particularly Alzheimer's disease.

Claim (Index 8):
An application of the reconstituted lipoprotein modified by monosialoteterahexosyl ganglioside of  claim 1  in preparing a drug carrier.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.93103
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10810919', '14085685', '11388135', '13463582', '10558984']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7671276082441384
- 35 USC 102 Novelty (BERT): 0.4925916185684957
- Combined Prediction Score: 0.7396740092765741
- Mean Citation Score: 206.734938
- Max Citation Score: 213.36919
- Similarity Product: 152.8520213991928

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test